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Purpose: To compare high-sensitivity C-reactive protein (hsCRP) levels and lipid profiles between Korean normal 
tension glaucoma (NTG) patients and healthy controls. 
Methods: This cross-sectional study included 38 Korean patients with NTG and 38 age- and sex-matched healthy 
control subjects. We excluded the patients with cardiovascular risk factors and other systemic diseases that might 
affect CRP levels and lipid profiles. Each patient underwent a Humphrey visual field examination and blood sam-
pling for hsCRP and lipid profile analyses. Subsequently, the NTG patients were classified into two groups based 
on their untreated intraocular pressure (IOP) level: low NTG (LNTG) with IOP≤13 mmHg (13 subjects) and high 
NTG (HNTG) with relatively high IOP (>13 and ≤21 mmHg, 25 subjects). The hsCRP levels and lipid profiles were 
compared between NTG patients and healthy controls, and between LNTG, HNTG, and healthy controls.
Results: There were no significant differences in hsCRP and lipid profiles between either the NTG patients and 
healthy controls, or between the LNTG, HNTG, and controls (p>0.05) after exclusion of Korean patients with 
cardiovascular risk factors. There was no significant association between hsCRP and visual field indices (p>0.05).
Conclusions: High-sensitivity C-reactive protein-related vascular inflammatory conditions may not be directly asso-
ciated with the development of NTG, regardless of the untreated IOP level.
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Normal tension glaucoma (NTG) is a clinical disease entity 
characterized by progressive thinning of the retinal nerve fiber 
layer and corresponding visual field loss in eyes with a normal 
range of intraocular pressure (IOP). Hypotheses associated with 
the development of  NTG include vascular dysregulatory factors, 
such as systemic blood pressure changes, ocular blood flow 
abnormalities, or vasospasm.
1-3 Many patients with glaucoma 
have an increased endothelin-1 plasma level.
4 In patients with 
primary open angle glaucoma (POAG), both systemic arterio-
sclerosis and sclerotic changes in the ocular vessels have been 
observed but also questioned.
5,6 Theoretically, these sclerotic 
changes in ocular vasculature might result in the impairment 
of ocular perfusion, with thickening of the vascular endothelial 
wall.
C-reactive protein (CRP) is an early acute phase reactant 
of inflammation, increasing in response to active infections 
or acute inflammatory processes. Minor elevations of  CRP are 
also present in chronic inflammatory situations, such as athe-
rosclerosis.
7 High-sensitivity CRP (hsCRP) is the most reliable 
and accessible marker of inflammation associated with athe-
rosclerosis.
8 It was also found to be correlated with impaired 
systemic endothelial vascular reactivity, and it was suggested 
that it may have a role in the pathogenesis of endothelial dys-
function and atherogenesis.
9,10 Risk factors for atherosclerosis 
are also important fields of interest. Any cardiovascular risk 
factor which can damage the vascular endothelial wall could 
increase the incidence of atherosclerotic change in the vessels. 
Dyslipidemia is one of the most important risk factors for the 
development of atherosclerosis.
The vascular dysfunction observed in patients with NTG 
may be a consequence of systemic vascular endotheliopathy.
11 
A population-based epidemiological survey in Japan revealed 
that 92% of POAG patients had a normal IOP range.
12 The 
prevalence of  NTG in the Japanese population is higher than 
that of Western countries.
13,14 Because of this, it could be 
speculated that there might be a different underlying mecha-
nism of pathogenesis for NTG in Asians.Korean J Ophthalmol Vol.23, No.3, 2009
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Table 1. Descriptive statistics for the demographics and clinical characteristics of the study patients
NTG eyes (n=38) Control eyes (n=38) p-value
Age (years) 52.2±16.1 (15-77) 52.0±15.6 (18-78) 0.910
Sex M:F=19:19 M:F=19:19 1.000
IOP (mmHg) 14.9±3.1 (10-21) 15.7±3.2 (10-19) 0.811
CCT (μm) 544.7±39.7 (495-630) 543.6±31.8 (478-636) 0.180
VF parameter
MD (dB) -6.0±5.7 (-23.4-0.5) -0.7±1.3 (-4.3-1.3) <0.001
*
PSD (dB) 5.2±4.4 (1.5-14.6) 1.7±0.3 (1.2-2.5) <0.001
*
GHT (Outside normal) 21 0 <0.001
*
Data are expressed as number (percentage) of subjects except for age: mean±SD (range). 
NTG=normal tension glaucoma; IOP=intraocular pressure; CCT=central corneal thickness; VF=visual field; MD=mean deviation; PSD= 
pattern standard deviation; GHT=glaucoma hemifield test.
* Statistical significance was found using an independent samples t-test (p<0.05). Chi-square tests were performed for the sex distribution and 
GHT.
The roles of atherosclerosis and dyslipidemia in the develop-
ment of  NTG have not yet been well defined. Leibovitch et al. 
found that plasma hsCRP levels were significantly higher in 
the NTG cases than in the controls.
15 However, Su et al. found 
no significant differences in hsCRP levels and lipid profiles 
in NTG patients when compared with age- and sex-matched 
controls.
16,17
We compared hsCRP and lipid profiles between patients 
with NTG and healthy controls in a homogenous Korean po-
pulation, in which NTG is presumably the most common type 
of open-angle glaucoma. We also investigated whether or not 
there was any difference in hsCRP and lipid profiles between 
NTG patients with high levels of  IOP and those with low IOP 
levels at the initial diagnosis of glaucoma.
Materials and Methods
We performed an age- and sex-matched case-control study 
with 38 newly diagnosed NTG patients and 38 healthy control 
subjects. All subjects were Korean. Each subject underwent a 
complete slit-lamp examination, including gonioscopy, IOP 
evaluation by Goldmann applanation tonometry, Humphrey 
visual field 24-2 full threshold or SITA standard examination 
(Humphrey Visual Field Analyzer II Model 745i, Carl Zeiss 
Meditec, Dublin, CA), and fasting blood sampling for hsCRP 
and lipid profiles including total cholesterol, low density lipo-
protein (LDL) cholesterol, high density lipoprotein (HDL) cho-
lesterol, and triglycerides. 
Normal tension glaucoma eyes (n=38) were defined as having: 
(1) an untreated IOP not exceeding 22 mmHg at different times 
of the day, from 9 AM to 5 PM (2) open anterior chamber angles 
on gonioscopy (3) glaucomatous optic neuropathy with thinning 
or notching of the neuroretinal rim and (4) reliable glaucoma-
tous visual field defects with Glaucoma Hemifield Test results 
(GHT) outside of 99% of the age-specific normal limits or a 
PSD outside of 95% of the normal limits.
Thirty-eight healthy volunteers were recruited from within 
the medical staff or clinic patients who had previously under-
gone cataract surgery. All subjects had a best-corrected visual 
acuity of 20/30 or better. The normal appearances of the optic 
nerve heads in both eyes were confirmed by a complete oph-
thalmic examination. The control eyes had intact neuroretinal 
rims; there was no evidence of disc hemorrhage, notching, ex-
cavation, or asymmetry of the vertical cup to disc ratio >0.2. 
No other pathologic ocular condition other than cataract was 
noted. No subject in the control group had a history of IOP 
elevation above 21 mmHg or ocular trauma. The visual fields 
of the control subjects were all normal. The GHT result was 
within normal limits, and the field did not meet any of the 
following criteria described above. 
Subjects with systemic diseases that might be associated 
with an increased level of CRP (hypertension, hypercholeste-
rolemia, diabetes mellitus, cerebral vascular accident, infection, 
chronic pulmonary obstructive disease or autoimmune diseases) 
were excluded from the study, thus none of our subjects were 
taking systemic medication that might affect CRP level, such 
as anti-hypertensives, cholesterol-lowering agents, or aspirin. 
Normal subjects were selected to match NTG patients by 
age and sex. For both NTG and control subjects, if both eyes 
met the inclusion criteria for the study, one eye was selected 
at random. The affected eye was selected in unilaterally di-
seased NTG patients. NTG patients were initially classified 
into two groups based on their untreated IOP levels: one with 
low IOP (≤13 mmHg low normal tension glaucoma, LNTG 
n=13), and the other with relatively high IOP (>13 and ≤ 21 
mmHg high normal tension glaucoma, HNTG n=25). Data are 
expressed as the mean±standard deviation. Continuous variables 
were compared between the NTG and control groups using 
the unpaired Student’s t-test and were compared among the 
LNTG, HNTG, and controls with the Kruskal-Wallis test. 
Categorical variables between groups were compared with the 
Chi-square test. Differences with a value of p<0.05 were con-
sidered statistically significant. Subsequently, NTG patients 
were classified based on the IOP cutoff point of 16 mmHg for 
the comparison of hsCRP and lipid profiles (IOP ≤16 mmHg, 
n=23 >16 and ≤21 mmHg, n=15). All applicable institutional 
and governmental regulations concerning the ethical use of 
human volunteers were followed during this study.J Choi, et al. CRP AND LIPID PROFILES IN KOREAN NTG PATIENTS
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Table 2. Descriptive statistics for the demographics and clinical characteristics of LNTG, HNTG, and control patients
LNTG eyes (n=13) HNTG eyes (n=25) Control eyes (n=38)  p-value
Age (years) 51.0±15.5 (15-77) 44.6±11.6 (24-65) 52.0±15.6 (18-78) 0.308
Sex M:F=7:6 M:F=12:13 M:F=19:19 0.940
IOP (mmHg) 12.4±1.5 (10-14) 17.3±1.9 (15-21) 15.7±3.2 (10-19) <0.001
*
CCT (μm) 531.8±34.8 (495-630) 543.6±31.8(495-608) 543.6±31.8 (478-636) 0.037
*
VF parameter
MD (dB) -6.8±7.0 (-23.4-0.4) -5.5±4.5 (-15.4-0.5) -0.7±1.3 (-4.3-1.3) <0.001
*
PSD (dB) 6.1±4.2 (1.6-13.0) 5.1±4.2 (1.5-14.6) 1.7±0.3 (1.2-2.5) <0.001
*
GHT (Outside normal) 7 14 0 <0.001
*
Data are expressed as number (percentage) of subjects except for age: mean ±SD (range).
NTG=normal tension glaucoma; IOP=intraocular pressure; CCT=central corneal thickness. VF=visual field; MD=mean deviation; PSD= 
pattern standard deviation; GHT=glaucoma hemifield test.
* Statistical significance was found using an independent samples t-test (p<0.05). Chi-square tests were performed for the sex distribution and 
GHT.
Table 3. Comparison of CRP and lipid profiles between NTG eyes and healthy controls
NTG eyes (n=38) Control eyes (n=38) p-value
high sensitivity CRP 0.13±0.19 (0.03-1.07) 0.12±0.18 (0.03-0.47) 0.772
total cholesterol 167.5±26.4(102-237) 181.0±36.0 (131-251) 0.063
LDL cholesterol 107.9±26.8 (65-180) 118.3±28.3 (81-187) 0.113
HDL cholesterol 53.1±13.4 (28-73) 54.9±13.4 (34-92) 0.553
triglycerides 114.8±75.4 (44-372) 108.1±65.1 (48-243) 0.680
There were no statistical significances in any of the variables between the study and control group (p>0.05, independent samples t-test).
Table 4. Comparison of CRP and lipid profiles between NTG eyes with low IOP (≤13 mmHg, LNTG), NTG eyes with 
relatively high IOP (>13 and ≤21 mmHg, HNTG), and healthy controls
LNTG eyes (n=13) HNTG eyes (n=25) Control eyes (n=38) p-value
high sensitivity CRP 0.14±0.14 (0.03-0.67) 0.13±0.22 (0.03-1.07) 0.12±0.18 (0.03-0.47) 0.739
total cholesterol 168.2±32.1 (102-237) 167.1±23.6 (124-213) 180.5±33.0 (131-251) 0.172
LDL cholesterol 107.4±32.3 (65-180) 108.1±23.7 (65-161) 118.3±28.3 (81-187) 0.250
HDL cholesterol 53.3±14.1 (28-67) 53.0±13.3 (33-73) 54.9±13.4 (34-92) 0.821
triglycerides 122.2±91.1 (54-372) 110.7±67.2 (44-195) 108.0±65.1 (48-243) 0.947
There were no statistical significances in any of the variables between each group (p>0.05, Kruskal-Wallis test).
Results
Table 1 presents descriptive statistics for the demographic 
and clinical characteristics of the study patients. All 38 NTG 
patients were Korean 19 (50.0%) were men and 19 (50.0%) 
were women. There were no significant differences in age, 
IOP, and central corneal thickness (CCT) between overall NTG 
subjects and normal controls (age, p=0.910 IOP, p=0.811; CCT, 
p=0.180). Visual field parameters (mean deviation (MD), pa-
ttern standard deviation (PSD)) were worse in patients with 
NTG (MD, p<0.001; PSD, p<0.001) than in control patients. 
Table 2 presents descriptive statistics for the demographic 
and clinical characteristics of the LNTG, HNTG, and control 
patients. Seven (53.8%) LNTG patients were men and six (46.2 
%) were women, while 12 (48.0%) HNTG patients were men 
and 13 (52.0%) were women. There was no significant diffe-
rence in age among the groups (p=0.940) however, IOP, CCT, 
MD, and PSD were different among the groups (IOP, p<0.001; 
CCT, p=0.037; MD, p<0.001; PSD, p<0.001). Table 3 shows 
descriptive statistics and comparisons of hsCRP and lipid pro-
files between NTG patients and control subjects. None of these 
biochemical parameters showed statistical significance between 
the NTG patients and the normal control subjects (hsCRP, 
p=0.772; total cholesterol, p=0.063; LDL cholesterol, p=0.113; 
HDL cholesterol, p=0.553; triglycerides, p=0.680). Table 4 shows 
descriptive statistics and comparisons of hsCRP and lipid pro-
files between the LNTG, HNTG, and the normal controls. There 
were no statistical significances in the differences in the para-
meters among the groups (hsCRP, p=0.739; total cholesterol, 
p=0.172; LDL cholesterol, p=0.250; HDL cholesterol, p=0.821; 
triglycerides, p=0.947). When the data was analyzed with an 
IOP cutoff point of 16 mmHg, there also was no statistical 
significance in hsCRP and lipid profiles between LNTG and 
HNTG subjects (hsCRP, p=0.131; total cholesterol, p=0.143; 
LDL cholesterol, p=0.191; HDL cholesterol, p=0.606, trigly-
cerides, p=0.180).Korean J Ophthalmol Vol.23, No.3, 2009
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Discussion
Our data showed that CRP level and lipid profiles were not 
different between NTG patients and normal controls. These 
results coincide with those of the article published by Su et 
al.
16,17 However, our data is contrary to the prior report by Lei-
bovitch et al.
15 which showed an increased level of hsCRP in 
NTG patients when compared with normal controls. In their 
study, they did not exclude patients with hypertension, DM, and 
other systemic diseases that can affect CRP level. As CRP and 
lipid profiles differ with age and race,
18 an age- and sex-matched 
case-control study in a homogenous population is most desi-
rable for the comparison of the biochemical parameters. In our 
study of Korean patients, the subjects with systemic diseases 
such as hypertension, hypercholesterolemia, ischemic heart 
disease, and cerebrovascular incidents were all excluded. In our 
study design, we thought a higher accuracy would be achieved 
if we determined the association between NTG and CRP level 
after excluding those patients with systemic diseases to mini-
mize the biasing effect of systemic morbidity. 
In contrast, other studies might produce different results if 
the systemic morbidity of subjects is not taken into account. 
There is evidence suggesting that atherosclerosis affects the 
peripheral circulation of the blood flow in the end-organs, re-
sulting in diseases such as ischemic heart disease and ischemic 
brain disease.
19,20 There is also evidence which suggests that 
the development of NTG is affected by reduced or unstable 
ocular blood flow,
2 and that atherosclerosis is the most typical 
cause of compromised blood flow due to the resulting vascular 
stiffness with vascular endothelial wall thickening. This sugge-
sts that the lack of association between CRP and lipid profiles 
with NTG in our series of patients does not rule out the possi-
bility of an association of atherosclerosis with NTG. A pros-
pective, population-based study will be needed to answer this 
question. 
The definition of  “normal tension” in NTG was derived from 
an old epidemiological survey by Leydhecker et al. on the IOP 
distribution in patients with no visual field defects.
21 Lee et 
al. showed that, in NTG patients with low IOP ≤13 mmHg, 
IOP-related parameters were not associated with functional 
and structural glaucomatous damages, while there was an asso-
ciation in NTG patients with relatively high IOP >13 mmHg, 
suggesting that there might be different subgroups within NTG 
patients based on the untreated IOP levels [Lee CH, Lee J, Choi 
J, Kook MS. Prediction of glaucomatous damage using central 
corneal thickness and 24-hour IOP profiles. AAO annual mee-
ting 2006 poster abstract]. In our study, there was no difference 
in CRP and lipid profiles when NTG subjects were classified 
by their untreated IOP levels, indicating that a direct linkage 
between the vascular inflammation associated with athero-
sclerosis and glaucoma is lacking in NTG eyes with differing 
IOP levels.
Iwase et al. reported the higher prevalence of  NTG among 
Japanese subjects in an epidemiological study.
12 The prevalence 
of cases of  POAG with IOP levels of 21 mmHg or less was 3.6 
%, whereas the prevalence for those with IOP levels of more 
than 21 mmHg was 0.3% in their study. The associations of the 
polymorphism of the endothelin receptor type A gene with NTG 
were reported only in Korean and Japanese populations.
22, 23 
These findings, differing from Western studies, raised the need 
for an investigation of vascular risk factors other than IOP in 
Asian populations. For example, a recent report suggested that 
circadian fluctuations in mean ocular perfusion pressure were 
associated with functional and glaucomatous damages in Korean 
NTG subjects.
2 We hypothesized that systemic atherosclerosis 
could jeopardize the local perfusion status of the ocular ve-
ssels. C-reactive protein levels and lipid profiles in this study 
functioned as a proxy for general atherosclerosis in the vessels. 
We found that these biochemical parameters did not differ bet-
ween NTG patients and the normal controls, nor did they differ 
between the NTG patients grouped according to their different 
IOP levels. Direct evidence that systemic endothelial dysfunc-
tion was associated with NTG was not obtained.
Our study has limitations due to the small groups sizes of 
NTG subjects and normal controls. Determining sample size 
is an important issue in a clinical study because samples that 
are too large may waste time, resources, and money, while sam-
ples that are too small may lead to inaccurate or non-applicable 
results. We did not calculate the sample size statistically in the 
present study as it was very difficult to assume the effect size 
of  NTG on hsCRP and lipid profiles as there are a very limited 
number of articles, which themselves are very controversial.
15-17 
Thus, our study should be regarded only as a pilot study. Ex-
clusion of the NTG subjects with systemic morbidity in our 
study could result in another type of selection bias, as it is 
known that there are heterogenous risk factors contributing 
to the development of  NTG. C-reactive protein levels may also 
vary in patients in different stages of glaucoma. Further inves-
tigations are needed to reveal the association of  CRP and lipid 
profiles with NTG patients according to the presence of sys-
temic cardiovascular disease.
In conclusion, our negative findings suggest that the hsCRP- 
related vascular inflammatory component may not be a direct 
risk factor for the development of NTG in Korean subjects 
who do not have systemic cardiovascular disease.
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